Skip to main content
Premium Trial:

Request an Annual Quote

HandyLab Gets $2M ATP Grant for DNA Analysis Device

NEW YORK, July 15 -Diagnostics startup HandyLab said today it has been awarded a $2 million ATP grant from the US National Institute of Standards and Technology to develop its portable DNA analysis device

 

The system under development uses microfluidics and electrochemical detection technologies, and is designed to process raw clinical and environmental samples. The system is being developed to perform PCR, RT-PCR, nucleic acid testing and bioassays for biodefense and for clinical diagnostics in hospital settings.

 

The Ann Arbor, Mich.-based company is attempting to develop this system as a low-cost and portable alternative to current options in field and point-of-care DNA, protein, and other clinical testing.

 

For a more in-depth view of HandyLab, see the October 2002 Genome Technology story.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.